Read + Share
Ushiyama Y, Horimoto Y, Murakami F, Ishizuka Y, et al. Relationship Between Daily Dose of Everolimus and Treatment Effect in Patients
With Luminal HER2-negative Metastatic Breast Cancer. Anticancer Res 2023;43:5253-5259.
PMID: 37909948
|
 |
|
Ushiyama Y, Horimoto Y, Murakami F, Ishizuka Y, et al. Relationship Between Daily Dose of Everolimus and Treatment Effect in Patients
With Luminal HER2-negative Metastatic Breast Cancer. Anticancer Res 2023;43:5253-5259.
PMID: 37909948
|
|
|
|